Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Revenue | 15.92bn | 16.33bn | 16.98bn | 14.54bn | 14.97bn | 15.77bn |
| Cost of revenue | 6.97bn | 6.97bn | 7.00bn | 6.51bn | 6.55bn | 6.82bn |
| Gross profit | 8.95bn | 9.36bn | 9.98bn | 8.03bn | 8.42bn | 8.95bn |
| Research and development | 2.17bn | 2.08bn | 2.10bn | 1.95bn | 1.88bn | 1.84bn |
| Selling, general and administrative | 5.09bn | 4.75bn | 5.03bn | 4.89bn | 4.91bn | 4.94bn |
| Interest expense | 473m | 492m | 510m | 455m | 429m | 427m |
| Pre-tax income | 1.39bn | 2.43bn | 2.60bn | 1.16bn | −802m | 2.22bn |
| Income tax | 172m | 686m | 404m | 103m | −485m | 389m |
| Net income | 1.22bn | 1.74bn | 2.19bn | 1.06bn | −330m | 1.83bn |
| Earnings per share | 1.30 | 1.87 | 2.36 | 1.14 | −0.36 | 1.99 |
| Earnings per share, diluted | 1.28 | 1.84 | 2.31 | 1.12 | −0.36 | 1.96 |
| Weighted average shares | 939m | 934m | 931m | 928m | 924m | 920m |
| Weighted average shares, diluted | 952m | 949m | 948m | 945m | 924m | 934m |
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 10.82bn | 13.59bn | 11.57bn | 11.94bn | 11.04bn | 13.95bn | 13.21bn | 14.48bn |
| Receivables | 6.49bn | 8.11bn | 5.53bn |
| Metric | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
| Operating cash flow | 5.17bn | 4.37bn |
| Depreciation and amortisation | 555m | 536m |
| Share-based compensation | 506m | 401m |
| Capital expenditure | 232m | 244m |
| Investing cash flow | −10.49bn | −12.98bn |
| Dividends paid | 1.58bn |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)
| 5.97bn |
| 5.86bn |
| 6.80bn |
| 5.39bn |
| 5.77bn |
| Inventory | 1.48bn | 1.22bn | 1.40bn | 1.25bn | 1.43bn | 1.29bn | 1.37bn | 1.23bn |
| Current assets | 31.91bn | 36.94bn | 32.74bn | 34.25bn | 35.34bn | 34.48bn | 30.54bn | 33.30bn |
| Goodwill | 74.71bn | 67.72bn | 67.40bn | 67.51bn | 66.07bn | 60.71bn | 61.09bn | 59.42bn |
| Total assets | 156.23bn | 151.88bn | 146.31bn | 148.59bn | 145.67bn | 137.18bn | 134.34bn | 133.85bn |
| Current liabilities | 40.10bn | 38.66bn | 35.14bn | 37.73bn | 35.11bn | 33.14bn | 28.85bn | 29.65bn |
| Short-term debt | 8.66bn | 6.42bn | 7.94bn | 8.95bn | 6.91bn | 5.09bn | 3.60bn | 3.60bn |
| Long-term debt | 57.71bn | 54.84bn | 55.17bn | 55.22bn | 56.37bn | 49.88bn | 52.98bn | 52.93bn |
| Total liabilities | 123.17bn | 119.14bn | 118.32bn | 121.00bn | 118.71bn | 109.78bn | 109.81bn | 109.75bn |
| Equity | 32.97bn | 32.65bn | 27.91bn | 27.59bn | 26.95bn | 27.31bn | 24.53bn | 24.10bn |
| Shares outstanding | — | 2.29bn | 2.29bn | 2.28bn | 2.28bn | 2.28bn | 2.28bn | 2.27bn |
| Shares issued | 2.29bn | 2.29bn | 2.29bn | 2.28bn | 2.28bn | 2.28bn | 2.28bn | 2.27bn |
| Treasury shares | 1.35bn | 1.35bn | 1.35bn | 1.35bn | 1.35bn | 1.35bn | 1.35bn | 1.35bn |
| 1.55bn |
| Financing cash flow | 2.72bn | 5.44bn |